Abstract
The in vitro synergistic activities of the beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam, combined with ampicillin, ticarcillin, mezlocillin, azlocillin, piperacillin, and apalcillin, were determined against 34 strains of members of the Enterobacteriaceae family, Pseudomonas aeruginosa, Aeromonas hydrophila, and Haemophilus influenzae with characterized plasmid or chromosomal beta-lactamases or both. Strains were tested against fixed concentrations of beta-lactamase inhibitors (8 micrograms/ml) combined with doubling dilutions of beta-lactams. Synergy was defined as a fourfold or greater decrease in the MIC of the beta-lactam. Against Enterobacteriaceae producing Richmond and Sykes class III and V plasmid-mediated beta-lactamases, synergy was obtained against most strains with YTR 830- and clavulanate-beta-lactam combinations, with sulbactam being less effective. Against Enterobacteriaceae producing class I chromosomal beta-lactamases, combinations containing YTR 830 or sulbactam were more synergistic than combinations containing clavulanate. Against strains producing class V PSE enzymes, all three inhibitors were synergistic with piperacillin and apalcillin against strains producing PSE-1, -3, and -4 enzymes, while the PSE-2-producing strain was resistant to all inhibitors. YTR 830-beta-lactam combinations were also synergistic against strains producing the novel beta-lactamases OHIO-1, TLE-1, AER-1, and ROB-1. Overall, YTR 830 with piperacillin or apalcillin was the most effective combination.
Full text
PDF![980](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d4a/180488/eed20c7d3d02/aac00172-0048.png)
![981](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d4a/180488/3424a9dfc5da/aac00172-0049.png)
![982](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d4a/180488/3c29f0bd8df2/aac00172-0050.png)
![983](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d4a/180488/6ac207e7ce40/aac00172-0051.png)
![984](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d4a/180488/bb8be79ee8b8/aac00172-0052.png)
![985](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d4a/180488/0f244dca00de/aac00172-0053.png)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Arisawa M., Then R. L. 6-Acetylmethylenepenicillanic acid (Ro 15-1903), a potent beta-lactamase inhibitor. I. Inhibition of chromosomally and R-factor-mediated beta-lactamases. J Antibiot (Tokyo) 1982 Nov;35(11):1578–1583. doi: 10.7164/antibiotics.35.1578. [DOI] [PubMed] [Google Scholar]
- Aronoff S. C., Jacobs M. R., Johenning S., Yamabe S. Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin. Antimicrob Agents Chemother. 1984 Oct;26(4):580–582. doi: 10.1128/aac.26.4.580. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brown R. M., Wise R., Andrews J. M., Hancox J. Comparative pharmacokinetics and tissue penetration of sulbactam and ampicillin after concurrent intravenous administration. Antimicrob Agents Chemother. 1982 Apr;21(4):565–567. doi: 10.1128/aac.21.4.565. [DOI] [PMC free article] [PubMed] [Google Scholar]
- File T. M., Jr, Tan J. S., Salstrom S. J., Johnson L. A., Douglas G. F. Timentin versus piperacillin or moxalactam in the therapy of acute bacterial infections. Antimicrob Agents Chemother. 1984 Sep;26(3):310–313. doi: 10.1128/aac.26.3.310. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hedges R. W., Medeiros A. A., Cohenford M., Jacoby G. A. Genetic and biochemical properties of AER-1, a novel carbenicillin-hydrolyzing beta-lactamase from Aeromonas hydrophila. Antimicrob Agents Chemother. 1985 Apr;27(4):479–484. doi: 10.1128/aac.27.4.479. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Holloway W. J. Treatment of infections in hospitalized patients with ticarcillin plus clavulanic acid. A comparative study. Am J Med. 1985 Nov 29;79(5B):168–171. doi: 10.1016/0002-9343(85)90153-6. [DOI] [PubMed] [Google Scholar]
- Medeiros A. A. Beta-lactamases. Br Med Bull. 1984 Jan;40(1):18–27. doi: 10.1093/oxfordjournals.bmb.a071942. [DOI] [PubMed] [Google Scholar]
- Medeiros A. A., Cohenford M., Jacoby G. A. Five novel plasmid-determined beta-lactamases. Antimicrob Agents Chemother. 1985 May;27(5):715–719. doi: 10.1128/aac.27.5.715. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Medeiros A. A., Hare R., Papa E., Adam C., Miller G. H. Gram-negative bacilli resistant to third-generation cephalosporins: beta-lactamase characterization and susceptibility to Sch 34343. J Antimicrob Chemother. 1985 Jun;15 (Suppl 100):119–132. doi: 10.1093/jac/15.suppl_c.119. [DOI] [PubMed] [Google Scholar]
- Minami S., Yotsuji A., Inoue M., Mitsuhashi S. Induction of beta-lactamase by various beta-lactam antibiotics in Enterobacter cloacae. Antimicrob Agents Chemother. 1980 Sep;18(3):382–385. doi: 10.1128/aac.18.3.382. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Neu H. C. Penicillins--new insights into their mechanisms of activity and clinical use. Bull N Y Acad Med. 1982 Nov;58(8):681–695. [PMC free article] [PubMed] [Google Scholar]
- Neu H. C. beta-Lactamase inhibitory activity of iodopenicillanate and bromopenicillanate. Antimicrob Agents Chemother. 1983 Jan;23(1):63–66. doi: 10.1128/aac.23.1.63. [DOI] [PMC free article] [PubMed] [Google Scholar]
- O'Callaghan C. H., Morris A., Kirby S. M., Shingler A. H. Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate. Antimicrob Agents Chemother. 1972 Apr;1(4):283–288. doi: 10.1128/aac.1.4.283. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Paisley J. W., Washington J. A., 2nd Combined activitiy of clavulanic acid and ticarcillin against ticarcillin-resistant, gram-negative bacilli. Antimicrob Agents Chemother. 1978 Aug;14(2):224–227. doi: 10.1128/aac.14.2.224. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rubin L. G., Medeiros A. A., Yolken R. H., Moxon E. R. Ampicillin treatment failure of apparently beta-lactamase-negative Haemophilus influenzae type b meningitis due to novel beta-lactamase. Lancet. 1981 Nov 7;2(8254):1008–1010. doi: 10.1016/s0140-6736(81)91214-9. [DOI] [PubMed] [Google Scholar]
- Scully B. E., Chin N. X., Neu H. C. Pharmacology of ticarcillin combined with clavulanic acid in humans. Am J Med. 1985 Nov 29;79(5B):39–43. doi: 10.1016/0002-9343(85)90127-5. [DOI] [PubMed] [Google Scholar]
- Yotsuji A., Minami S., Araki Y., Inoue M., Mitsuhashi S. Inducer activity of beta-lactam antibiotics for the beta-lactamases of Proteus rettgeri and Proteus vulgaris. J Antibiot (Tokyo) 1982 Nov;35(11):1590–1593. doi: 10.7164/antibiotics.35.1590. [DOI] [PubMed] [Google Scholar]